Azione ATT ABATTIS BIOCEUTICALS CORP.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati
Strumento inattivo

Altre lingue Abattis Bioceuticals Corp. Canadian Securities Exchange

Azioni

ATT

CA00258G1037

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019
Abattis Bioceuticals Corp. Announces Board Changes
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of NutriVida Corp.
Abattis Bioceuticals Corp. Reports Earnings Results for the Third Quarter Ended June 30, 2019
Abattis Bioceuticals Corp.'s Equity Buyback announced on August 7, 2018, has expired.
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2018
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of Winston Resources Inc..
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) completed the acquisition of Pro Natura BV from The Catalyst Capital Group Inc.
Abattis Bioceuticals : Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
Abattis Bioceuticals Corp. Announces Management Changes
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) agreed to acquire Pro Natura BV from The Catalyst Capital Group Inc. for €15.7 million.
Abattis Bioceuticals Corp. Announces Resignations in Board
British Columbia Securities Commission Removes Temporary Order on Abattis Bioceuticals Corp
Abattis Bioceuticals Corp Announces Launch of Its New Website and Provide an Operational Update
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) signed a letter of intent to acquire NutriVida Corp. for CAD 15 million.
Abattis Bioceuticals Corp Signs a Distribution Agreement with Shefield &Sons Tobacconists Inc. to Sell the Abattis Vaporizer Line in all Shefield &Sons Stores Across Canada
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) acquired Select Strains Inc. for $3.5 million.
Abattis Bioceuticals Corp. Announces Executive Changes
Abattis Intends To Seek Acquisitions
Abattis Bioceuticals Corp. Announces Board Changes
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione ATTB.F
  4. Azione ATT
  5. Notizie Abattis Bioceuticals Corp.
  6. Altre lingue